ABOUT: Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson’s disease and related disorders. Inhibikase’s multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program IkT-148009, an Abelson […]
https://finance.yahoo.com/news/china-ev-stocks-rally-after-xpeng-unveils-stunning-cost-savings-new-production-process-132705256.html
Eir Nolsoe Mon, April 17, 2023, 1:00 AM EDT Nearly half a million landlords are expected to sell up in the next five years, as the baby boomer generation retires and cashes in their nest […]
Patrick Wingrove Wed, April 12, 2023, 3:26 PM EDT (YAHOO!) By Patrick Wingrove (Reuters) -Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive […]
THIS INTERVIEW HAS EXPIRED
THIS INTERVIEW HAS EXPIRED
EDISON, N.J., April 11, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint Security announced today that Visualnet Media has become a Zerify Reseller. […]
https://finance.yahoo.com/m/78d84b65-b76f-3bca-8a1b-2e8e5a7b503a/saudi-arabia-led-oil-cuts-run.html
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com